HOPA 2020: Bortezomib-Based Induction for Myeloma Can Be Transitioned to Ixazomib-Lenalidomide-Dexamethasone Effectively and Safely
Depth of response is then improved substantially.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.